[1] Kazazian HH, Jr., Moran JV. Mobile DNA in Health and Disease. N Engl J Med 2017;377:361-70.
[2] Burns KH. Transposable elements in cancer. Nat Rev Cancer 2017;17:415-24.
[3] Scott EC, Gardner EJ, Masood A, Chuang NT, Vertino PM, Devine SE. A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer. Genome Res 2016;26:745-55.
[4] Hancks DC, Kazazian HH, Jr. Roles for retrotransposon insertions in human disease. Mob DNA 2016;7:9.
[5] Ostertag EM, DeBerardinis RJ, Goodier JL, et al. A mouse model of human L1 retrotransposition. Nat Genet 2002;32:655-60.
[6] An W, Han JS, Wheelan SJ, et al. Active retrotransposition by a synthetic L1 element in mice. Proc Natl Acad Sci U S A 2006;103:18662-7.
[7] KanoH, Godoy I, Courtney C, et al. L1 retrotransposition occurs mainly in embry ogenesis and creates somatic mosaicism. Genes Dev 2009;23:1303-12.
[8] Richardson SR, Gerdes P, Gerhardt DJ, et al. Heritable L1 retrotransposition in the mouse primordial germline and early embryo. Genome Res 2017;27:1395-405.
[9] Newkirk SJ, An W. L1 Regulation in Mouse and Human Germ Cells. In: Cristofari G, ed. Human Retrotransposons in Health and Disease: Springer International Publishing; 2017:29-61.
[10] Bourc'his D, Bestor TH. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 2004;431:96-9.
[11] Newkirk SJ, Lee S, Grandi FC, et al. Intact piRNA pathway prevents L1 mobilization in male meiosis. Proc Natl Acad Sci U S A 2017;114:E5635-E44.
[12] Zamudio N, Barau J, Teissandier A, et al. DNA methylation restrains transposons from adopting a chromatin signature permissive for meiotic recombination. Genes Dev 2015;29:1256-70.